News/ News/ Oncology BMS invests $12m in cancer immunotherapy tie-up with Compugen Richard Staines Bristol-Myers Squibb, cancer, Compugen, Oncology 0 Comment Bristol-Myers Squibb has invested $12 million in Compugen, a biotech that is investigating a new approach that could Share X BMS invests $12m in cancer immunotherapy tie-up with Compugen https://pharmaphorum.com/news/bms-invests-12m-in-cancer-immunotherapy-tie-up-with-compugen/
